Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Circulating dendritic cells from celiac disease patients display a gut‐homing profile and are differentially modulated by different gliadin‐derived peptides

  • Escudero-Hernández, Celia
  • Martín, Álvaro
  • Pedro Andrés, Rodrigo de
  • Fernández-Salazar, Luis
  • Garrote, José Antonio
  • Bernardo, David
  • Arranz, Eduardo
[Scope]: Circulating dendritic cell (DC) and monocyte subsets contribute to the pool of intestinal DC and macrophages in celiac disease (CeD), an autoimmune gut disorder triggered by dietary gluten. Here, this study aims to characterize these circulating subsets in CeD and assess the effect of different gliadin‐derived peptides on conventional DC (cDC)., [Methods and results]: Flow cytometry profiling of peripheral blood mononuclear cells reveals a slight decrease in the proportion of plasmacytoid and type 1 cDC in gluten‐free diet (GFD)‐treated CeD patients. In comparison to healthy donors, DC and monocyte subsets from active and GFD‐treated CeD patients display an increased gut‐homing profile. Type 2 cDC (cDC2) are sorted and stimulated with the gliadin‐derived peptides 8‐mer, 19‐mer, and 33‐mer. All peptides induce cDC2 maturation, although the profile is different. While peptide 8‐mer induces a Th1/Th17 pro‐inflammatory cytokine profile in active CeD patients, cDC2 primed with peptide 33‐mer displays a higher capacity to promote gut‐homing CCR9+ expression onto autologous T‐cells., [Conclusion]: Distinct gliadin‐derived peptides elicit different effects on cDC2 phenotype and function. This effect is compatible with a model where diverse gliadin peptides may cooperate to promote full cDC2 activation and the subsequent T‐cell response in genetically predisposed individuals., This research was financially supported by Asociación de Celiacos y Sensibles al Gluten de Madrid (Spain), the Spanish Ministry of Science (RYC‐2017‐21606), and the Spanish Ministry of Economics and Competitiveness (RTC‐2014‐2401)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Profiling of Human Circulating Dendritic Cells and Monocyte Subsets Discriminates between Type and Mucosal Status in Patients with Inflammatory Bowel Disease

  • Ortega Moreno, Lorena
  • Fernández-Tomé, Samuel
  • Chaparro, María
  • Marin, Alicia C.
  • Mora-Gutiérrez, Irene
  • Santander, Cecilio
  • Baldan-Martin, Montserrat
  • Gisbert, Javier P.
  • Bernardo, David
[Background]: Intestinal dendritic cells (DC) and macrophages drive disease progression in patients with inflammatory bowel disease (IBD). We aimed to characterize the activation and homing profile of human circulating DC and monocyte subsets in healthy control patients (CP) and IBD patients., [Methods]: Eighteen CP and 64 patients with IBD were categorized by diagnoses of Crohn disease (CD) and ulcerative colitis (UC), either endoscopically active (inflamed) or quiescent. Circulating type 1 conventional DC, type 2 conventional DC, plasmacytoid DC, classical monocytes, nonclassical monocytes, and intermediate monocytes were identified by flow cytometry in each individual and characterized for the expression of 18 markers. Association between DC/monocytes and IBD risk was tested by logistic regression. Discriminant canonical analyses were performed to classify the patients in their own endoscopy category considering all markers on each subset., [Results]: CCRL1, CCR3, and CCR5 expression on circulating type 1 DC; CCRL1 expression on nonclassical monocytes; and CCR9 and β7 expression on classical monocytes allowed us to discriminate among the different study groups. Indeed, the same markers (excluding β7) were also associated with IBD when all DC and monocyte subsets were considered at the same time., [Conclusions]: Monitoring the phenotype of human circulating DC and monocyte subsets may provide novel tools as biomarkers for disease diagnosis (CD/UC) or mucosal status (inflamed/noninflamed) in the absence of an invasive colonoscopy., This work was supported by the Spanish Ministry of Science (SAF2014-56642-JIN; RYC-2017–21606), the Instituto de Salud Carlos III (PIE13/00041), the Sara Borrell fellowship CD17/00014), the Asociación Española de Gastroenterología (Becas Nuevos Investigadores 2016), and the Community of Madrid (Consejería de Educación, Juventud y Deporte, Programa de Garantía Juvenil 2015 and 2016; Universidad Autónoma de Madrid, Ayudas Atracción de Talento modalidad 2 2017 [BMD-5800]).